Tsukuba, Japan

Naoshi Yamamoto


Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2018-2019

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Naoshi Yamamoto: Innovator in Morphinan Derivatives

Introduction

Naoshi Yamamoto is a prominent inventor based in Tsukuba, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of morphinan derivatives. With a total of 2 patents, his work focuses on therapeutic agents that target orexin receptors.

Latest Patents

Yamamoto's latest patents include innovative compounds that serve as prophylactic or therapeutic agents for various diseases related to orexin receptors. One of his notable inventions is a morphinan derivative that exhibits excellent selectivity and antagonism against orexin receptors. This compound is designed to provide therapeutic and prophylactic effects on drug dependence. Another patent involves a morphinan derivative that can be used as an analgesic and antipruritic drug, showcasing its versatility in medical applications.

Career Highlights

Throughout his career, Naoshi Yamamoto has worked with esteemed institutions such as the University of Tsukuba and Nippon Chemiphar Co., Ltd. His research has led to advancements in understanding and treating conditions associated with orexin receptors, making him a valuable contributor to the pharmaceutical industry.

Collaborations

Yamamoto has collaborated with notable colleagues, including Hiroshi Nagase and Yoko Irukayama. These partnerships have facilitated the exchange of ideas and expertise, further enhancing the impact of his research.

Conclusion

Naoshi Yamamoto's innovative work in morphinan derivatives has the potential to revolutionize therapeutic approaches for drug dependence and related conditions. His contributions to the field underscore the importance of continued research and collaboration in advancing medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…